395 related articles for article (PubMed ID: 16078679)
1. [Update of PDE5 inhibitors as treatment of ED].
Lu YN; Chen B
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):552-5. PubMed ID: 16078679
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 5 inhibitors for erectile dysfunction.
Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction].
Shen ZJ; Yu YL
Zhonghua Nan Ke Xue; 2005 Aug; 11(8):631-4. PubMed ID: 16138588
[TBL] [Abstract][Full Text] [Related]
4. [Advances in application of sildenafil to erectile dysfunction].
Li Z; Wu ZM; Wang YX
Zhonghua Nan Ke Xue; 2005 Jun; 11(6):473-6. PubMed ID: 15999498
[TBL] [Abstract][Full Text] [Related]
5. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
[TBL] [Abstract][Full Text] [Related]
6. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
Doggrell S
Int J Impot Res; 2007; 19(3):281-95. PubMed ID: 17183346
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
8. [A decade's evidence review of sildenafil citrate].
Zhang K; Zhu JC
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):3-6. PubMed ID: 19288739
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
Chen Q; Wang N; Yao F; Lu X
Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
Vickers MA; Satyanarayana R
Int J Impot Res; 2002 Dec; 14(6):466-71. PubMed ID: 12494279
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of vardenafil for men with erectile dysfunction].
Zhu J; Jiang H
Zhonghua Nan Ke Xue; 2004 Sep; 10(9):704-10. PubMed ID: 15497716
[TBL] [Abstract][Full Text] [Related]
12. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
Ishii N; Nagao K; Fujikawa K; Tachibana T; Iwamoto Y; Kamidono S
Int J Urol; 2006 Aug; 13(8):1066-72. PubMed ID: 16903931
[TBL] [Abstract][Full Text] [Related]
13. Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK.
Kell PD; Hvidsten K; Morant SV; Harnett JP; Bridge S
BJU Int; 2007 Apr; 99(4):860-3. PubMed ID: 17378846
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
Safarinejad MR; Kolahi AA; Ghaedi G
BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the efficacy and safety of sildenafil citrate in the geriatric population.
Müller A; Smith L; Parker M; Mulhall JP
BJU Int; 2007 Jul; 100(1):117-21. PubMed ID: 17552959
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase type 5 inhibitors: the day after.
Hatzimouratidis K; Hatzichristou D
Eur Urol; 2007 Jan; 51(1):75-88; discussion 89. PubMed ID: 16949200
[TBL] [Abstract][Full Text] [Related]
18. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors.
Taylor J; Baldo OB; Storey A; Cartledge J; Eardley I
BJU Int; 2009 May; 103(10):1392-5. PubMed ID: 19154494
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of vardenafil in the treatment of erectile dysfunction in men with hypertension].
Li HJ
Zhonghua Nan Ke Xue; 2006 Oct; 12(10):953-6. PubMed ID: 17121032
[TBL] [Abstract][Full Text] [Related]
20. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
